Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Agilent; AB Sciex; Roche; Warnex; Chronix Biomedical

NEW YORK (GenomeWeb News) – Agilent Technologies said this week that Erasmus Medical Center in Rotterdam, Netherlands, will use the firm's SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part of the Erasmus Rucphen Family study to identify genetic risk factors for some complex genetic disorders. As part of the project, researchers are sequencing the exomes of 1,500 samples.

AB Sciex this week said that it has opened a new application and training center at its Singapore biomedical hub. It said the new center will serve researchers in Southeast Asia, Australia, New Zealand, Japan, and Korea, and it will complement the regional application support center the firm opened last year in Shanghai, China.

Roche said this week that its board of directors has proposed a 3 percent dividend increase for 2011 to CHF 6.80 ($7.39) per share. If the proposal is approved by shareholders, Roche said that 55 percent of its net income would be distributed to shareholders as dividends.

Warnex said that the Toronto Stock Exchange has agreed to extend the date of delisting of its common shares to the close of business on March 19. The firm said that it is exploring "various options" in light of the scheduled delisting. It also said that Persistence Capital Partners has agreed to extend the maturity date of the two outstanding convertible debentures of Warnex that it holds in the aggregate amount of C$1.4 million (US$1.4 million)to March 19.

Chronix Biomedical has opened a sequencing lab in Brookings, SD. The San Jose, Calif.-based firm said that the lab will offer sequencing services to academic and pharmaceutical researchers in support of their biomarker programs.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.